Genelux GNLX
NASDAQ GNLX
$2.48 -0.04 (-1.59%)
At close: Sep 10, 2026 · 4:00 PM EDT

Genelux (GNLX) Other financing activities (2023 - 2026)

Genelux (GNLX) posted Other financing activities of $13000.0 for Q1 2026, down 93.81% on a QoQ basis from $210000.0 in Q4 2025, and down 7.14% year-over-year from $14000.0 in Q1 2025.

Analysis

Genelux (GNLX) Other financing activities (2023 - 2026) Analysis & Trends

Genelux has reported Other financing activities for 4 years, with the latest figure at $13000.0 in Q1 2026.

  • On a quarterly basis, Other financing activities fell 7.14% year-over-year to $13000.0 in Q1 2026; TTM through Mar 2026 was $223000.0, a 1492.86% increase from a year earlier, with the FY2025 full-year figure at $224000.0, down 67.44% from the prior year.
  • Other financing activities was $13000.0 for Q1 2026 at Genelux, down from $210000.0 in the prior quarter.
  • The five-year high for Other financing activities was $14.5 million in Q1 2023, with the low at $1321.0 in Q3 2023.
  • Average Other financing activities over 4 years is $2.6 million, with a median of $112000.0 recorded in 2025.
  • The sharpest annual moves came in 2025 and 2026: Other financing activities tumbled 97.97% in 2025, then decreased 7.14% in 2026.
  • Over 4 years, Other financing activities stood at $1321.0 in 2023, then soared by 51981.76% to $688000.0 in 2024, then plunged by 69.48% to $210000.0 in 2025, then tumbled by 93.81% to $13000.0 in 2026.
  • The last three Other financing activities figures came in at $13000.0 (Q1 2026), $210000.0 (Q4 2025), and $14000.0 (Q1 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn
10 Genelux 108.17 Mn 108.17 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 13,000.00
Dec 31, 2025 210,000.00
Mar 31, 2025 14,000.00
Mar 31, 2024 688,000.00
Sep 30, 2023 1,321.00
Mar 31, 2023 14.50 Mn